M1 Kliniken (M12.DE) stock: key figures, P/E, revenue and dividend

Health Care · Germany · ISIN DE000A0STSQ8

Price
18.78 EUR
Market cap
348.47 m EUR
P/E (2025)
15.74
P/S (2025)
0.96
Dividend yield
6.39 %
Net margin
6.04 %
Return on equity (ROE)
14.67 %
Return on assets (ROA)
11.62 %

M1 Kliniken financials

Fiscal year20242025
Revenue339.00 m EUR364.00 m EUR
Gross profit63.00 m EUR47.00 m EUR
Operating income25.75 m EUR34.19 m EUR
EBIT26.00 m EUR36.00 m EUR
Net income16.00 m EUR22.00 m EUR
Diluted EPS – continuing operations0.86 EUR1.19 EUR

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About M1 Kliniken

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.